Literature DB >> 10722652

Smad6 as a transcriptional corepressor.

S Bai1, X Shi, X Yang, X Cao.   

Abstract

Smad6 and Smad7, a subgroup of Smad proteins, antagonize the signals elicited by transforming growth factor-beta. These two Smads, induced by transforming growth factor-beta or bone morphogenetic protein (BMP) stimulation, form stable associations with their activated type I receptors, blocking phosphorylation of receptor-regulated Smads in the cytoplasm. Here we show that Smad6 interacts with homeobox (Hox) c-8 as a transcriptional corepressor, inhibiting BMP signaling in the nucleus. The interaction between Smad6 and Hoxc-8 was identified by a yeast two-hybrid approach and further demonstrated by co-immunoprecipitation assays in cells. Gel shift assays show that Smad6, but not Smad7, interacts with both Hoxc-8 and Hoxa-9 as a heterodimer when binding to DNA. More importantly, the Smad6-Hoxc-8 complex inhibits interaction of Smad1 with Hoxc-8- and Smad1-induced transcription activity. These data indicate that Smad6 interacts with Hox transcription factors as part of the negative feedback circuit in the BMP signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722652     DOI: 10.1074/jbc.275.12.8267

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Smad6 recruits transcription corepressor CtBP to repress bone morphogenetic protein-induced transcription.

Authors:  Xia Lin; Yao-Yun Liang; Baohua Sun; Min Liang; Yujiang Shi; F Charles Brunicardi; Yang Shi; Xin-Hua Feng
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

Review 2.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 3.  Molecular basis for skeletal variation: insights from developmental genetic studies in mice.

Authors:  C Kappen; A Neubüser; R Balling; R Finnell
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2007-12

4.  Smad6 inhibits the transcriptional activity of Tbx6 by mediating its degradation.

Authors:  Yue-Lei Chen; Bin Liu; Zhen-Ning Zhou; Rui-Ying Hu; Cong Fei; Zhi-Hui Xie; Xiaoyan Ding
Journal:  J Biol Chem       Date:  2009-06-26       Impact factor: 5.157

Review 5.  Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma.

Authors:  Bhavna Rani; Yuan Cao; Andrea Malfettone; Ciprian Tomuleasa; Isabel Fabregat; Gianluigi Giannelli
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 6.  New molecular medicine-based scar management strategies.

Authors:  Anna I Arno; Gerd G Gauglitz; Juan P Barret; Marc G Jeschke
Journal:  Burns       Date:  2014-01-15       Impact factor: 2.744

Review 7.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

8.  Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis.

Authors:  Suntaek Hong; Hye-Youn Kim; Jooyoung Kim; Huyen Trang Ha; Young-Mi Kim; Eunjin Bae; Tae Hyung Kim; Kang Choon Lee; Seong-Jin Kim
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

9.  Bone morphogenetic protein 2-induced osteoblast differentiation requires Smad-mediated down-regulation of Cdk6.

Authors:  Toru Ogasawara; Hiroshi Kawaguchi; Shigeki Jinno; Kazuto Hoshi; Keiji Itaka; Tsuyoshi Takato; Kozo Nakamura; Hiroto Okayama
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

10.  Bare bones pattern formation: a core regulatory network in varying geometries reproduces major features of vertebrate limb development and evolution.

Authors:  Jianfeng Zhu; Yong-Tao Zhang; Mark S Alber; Stuart A Newman
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.